US stock MEIP surges over 33% today, market capitalization rises to $41.24 million
According to ChainCatcher, market sources report that MEI Pharma (NASDAQ: MEIP) surged over 33% today, with its market capitalization rising to $41.2431 million.
Previous reports indicated that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation of U.S. pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. More than $100 million in funding commitments have already been made to the project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chainlink spot ETF expected to launch this week, Grayscale plans to complete private trust conversion
CoinShares withdraws ETF applications for XRP, Solana, and Litecoin
Yearn yETH attacked, approximately $3 million worth of ETH flows into Tornado Cash
The on-chain holdings value of US spot Bitcoin ETFs has reached $150 billions.
Trending news
MoreCrypto prices
More
